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The  calcium  sulfate  (CS)  tablets  exhibit  excellent  osteoinductive  and osteoconductive  characteristics,  they
can be used  to repair  bone  defects.  However,  the  degradation  rate  of  CS  tablets  is very  fast.  The  present
study  demonstrates,  for the ﬁrst  time,  that the  degradation  rate  of  CS  tablets  can  be  manipulated  through
the  use  of  sintering  technique.  Firing  the  CS  tablets  to a  temperature  of 1100 ◦C  increases  their relativevailable online 9 April 2013
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density  to  a value  above  90%.  The  density  can  be further  enhanced  to above  95% through  the  addition  of
1  wt%  sintering  additives.  The  sintered  CS  tablets  with  the  addition  of  sintering  additives  exhibit  a  high
strength  and  a low  cytotoxicity.  More  importantly,  the  degradation  rate  is  tunable  through  the  choice  of
sintering  additives.
©  2013  The  Ceramic  Society  of  Japan  and  the Korean  Ceramic  Society.  Production  and  hosting  by
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. Introduction
Every year around 2 million patients undergo bone graft surgery
o repair their bone defects [1,2]. Along with the progress in the
evelopment of bioceramics, the use of bone graft substitutes to
eplace fractured bone has increased rapidly. Bioceramics are gen-
rally classiﬁed into two groups, resorbable or non-resorbable, in
erms of their degradation ability within the human body. The non-
esorbable ceramic is foreign to the human body for a very long
ime. The resorbable ceramic is degraded and absorbed into the
uman body as new bone is formed [1,3–5]. Several requirements
re needed for such bone graft materials [6]: ﬁrst of all, the bone
raft material should be osteoinductive and osteoconductive in
rder to enhance new bone formation and growth. In doing so, they
hould not cause adverse biological reactions, including deformity,
ain or discomfort, fracture, or transmission of disease, excessive
leeding, etc. Secondly, the strength of the bulk bone grafts should
e high enough to withstand external loads. Fast degradation may
esult in gaps or stress concentration [6], so the bone grafts should
ot degrade any faster than the formation of new bone. Moreover,∗ Corresponding author. Tel.: +886 2 33663899; fax: +886 2 23659800.
E-mail address: tuan@ntu.edu.tw (W.-H. Tuan).
eer review under responsibility of The Ceramic Society of Japan and the Korean
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ttp://dx.doi.org/10.1016/j.jascer.2013.03.007
t
i
p
o
b
2
B
(
AElsevier  B.V.  All  rights  reserved.
he formation of new bone depends strongly on the physical condi-
ions of the patient. For example, the bone growth rate of a young
erson is usually faster than that of an aged one. Thus, the bone sub-
titute should be designed with a custom-made degradation rate
ppropriate to each patient’s conditions.
Due to the self-setting characteristic and biocompatibility of
alcium sulfate (CS) powder, it has been used as a ﬁller for bone
ractures as early as 1892 [6–11]. The tablets prepared by press-
ng CS powder have now been used as ﬁllers for bone defects [6].
lthough using pure CS can meet the ﬁrst requirement above (i.e.
steoinductive and osteoconductive), previous in vivo studies have
ndicated that the degradation rate of the CS tablet is far too fast [7],
hich may  inﬂuence the regeneration of bone [6,7,12–14]. Further-
ore, the strength of the CS tablet was very low [7]. It is essential
o increase strength and reduce degradation rate in order to use
ulk CS as a bone graft substitute.
The strength of ceramic powder compacts can usually be
nhanced through the use of a sintering technique. Nonetheless,
o the surprise of the present authors, no investigations have ever
een conducted on the sintering behavior of CS.
In the present study, the sintering behavior of CS is under inves-
igation. The purpose of the present study is to analyze the potential
n preparation of bulk CS with a tunable biodegradation rate. The
ossibility of using sintering additives to enhance the densiﬁcation
f CS is explored. Biodegradation and cytotoxicity tests have also
een conducted to evaluate the biocompatibility of the sintered CS.
. Experimental procedureThe reagent-grade CS hemihydrate (CaSO4·1/2 H2O,  CSH, J.T.
aker, New Jersey, USA) powder was ball milled with silicon oxide
SiO2, Ceramet Co., Taoyuan, Taiwan), phosphorus pentoxide (P2O5,
cros, New Jersey, USA), calcium oxide (CaO, Acros, New Jersey,
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Table  1
Sintering additives used for the CaSO4-based specimens. The microstructure characteristics and degradation behaviors for the specimens after sintering at 1100 ◦C for 1 h
are  also shown.
Specimens CS CS1SP CS1SPN CS1SPC CS1SPCN
Sintering additives/wt%
CaSO4 100 99 99 99 99
SiO2 – 0.8 0.71 0.59 0.56
P2O5 – 0.2 0.13 0.15 0.11
CaO  – – – 0.26 0.21
NaHCO3 – – 0.16 – 0.12
Relative density/% 91.6 ± 1 94.9 ± 0.1 92.2 ± 0.6 95.3 ± 0.7 93.3 ± 0.2
Grain  size/m 20–50 2–10 2–10 2–10 2–10
Degradation timea (days) 11 – – – 50b
Degradation rate (%/day) 9 – – – 2
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Fig. 1. Relative density of the CaSO4-based specimens as a function of sintering
temperature. Five specimens were used for each datum point. Error bars show ±one
standard deviation.
Fig. 2. X-ray diffraction patterns for the CaSO -based specimens after sintering at
1
f
la Time needed for complete degradation.
b Estimated by using the extrapolation from the data shown in Fig. 6.
SA), and sodium hydrocarbonate (NaHCO3, Nacalal Tesque, Inc.,
yoto, Japan) powders in ethanol for 4 h. The compositions of the
pecimens and their notation used in the present study are listed in
able 1. The milling media was zirconia balls. The slurry was  dried in
 rotary evaporator to remove the ethanol, and then sieved through
 #150 plastic mesh. The mixed powders were consolidated into
iscs 10 mm in diameter and 3 mm in thickness at a uniaxial pres-
ure of 25 MPa. The discs were sintered at a temperature varying
rom 900 ◦C to 1200 ◦C in air for 1 h, with heating and cooling rates
f 3 ◦C/min.
The phase analysis was conducted using X-ray diffractometry
XRD, PW1830, Philips Co., The Netherlands) at 40 kV and 30 mA
ith a scanning rate of 3◦ 2/min. The microstructure was observed
sing a ﬁeld-emission scanning electron microscopy (FESEM-1530,
EO Instrument Co., Cambridge, UK). The compressive strength of
pecimen discs with a diameter to height ratio of 1:1 was  measured
y using a universal testing machine (MTS 810, MTS  Co., USA). The
isplacement rate was 0.96 mm/min. For the evaluation of degra-
ation behavior, the CS and CS1SPCN specimens were soaked in
ank’s solution at 37.5 ◦C. Eight specimens were used for each test-
ng condition. The ratio of specimen to Hank’s solution was  kept
t 1 g to 10 mL.  The weight loss and pH values were recorded on
 daily basis for 28 days. In order to maintain a degradation rate
ore realistic to human body conditions, the Hank’s solution was
reshly replaced every day.
The cytotoxicity test and cell proliferation assay were carried
ut as follows. The extracts from CS1SP, CS1SPN, CS1SPC and
S1SPCN specimens were prepared by following the ISO 10993-
 protocol. The extract of each specimen was then examined by
sing a cell proliferation assay. The L929 mouse ﬁbroblast cells
ere used in this assay. The cells were cultured in a medium (min-
mum essential medium, MEM)  composed of 10% heat-inactivated
orse serum (HS), sodium bicarbonate (3.7 g/L), and 1% penicillin
100 U/mL) with streptomycin (100 g/mL). The L929 cells were
ultured with the media containing the extracts from the CS-based
pecimens in a 96-well plate with cell density of 104 cells/100 L
n each well. The cell density after culturing in an incubator at 37 ◦C
ith 5% CO2 for 24, 48, and 72 h was estimated by using an auto-
atic cell counter (CountessTM, Invitrogen Co., USA). Six specimens
or each group were used.
The microculture tetrazolium (MTT) assay was also used to eval-
ate the cytotoxicity of the sintered CS-specimens. The L929 cells
ere seeded in 96-well plates with cell density of 104 cells/100 L
or each well. Afterward, the cells were cultured in the presence
f the extracts for 24 h. The cells were washed by using phos-
hate buffered solution (PBS). An amount of 10 L MTT  reagent
3-(4,5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide)
as then added, and cultured in the incubator at 37 ◦C in 5% CO2 for
 h. A dimethyl sulfoxide (DMSO) solution was added and cultured
T
m
i
t4
100 ◦C for 1 h.
or another 10 min  to form a purple solution. The absorbance of
ight with 540 nm wavelength was  measured by an ELISA reader.
he MEM  with 10 vol% DMSO was  used as the positive control;
eanwhile MEM  was  used as the negative control for the compar-son and reliability. Six specimens for each group were used in this
est.
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. Results
The relative density of the CS-based specimens as a function
f sintering temperature is shown in Fig. 1. Five specimens were
sed to calculate the average value for each group. The highest rel-
tive density could be reached after the sintering at 1100 ◦C for
 h. Furthermore, when sintering temperature was 1100 ◦C, the
ange of variation in density among all specimens was  quite small.
s
a
oSPC and (e) CS1SPCN specimens after sintering at 1100 ◦C for 1 h.
he specimen density decreased as the sintering was  carried out
t 1200 ◦C. The CS-based specimens for subsequent evaluations
ere thus prepared by sintering at 1100 ◦C for 1 h unless otherwise
tated. A maximum density of 92% was obtained for the pure CS
pecimen. After adding a small amount (1 wt%) of various sintering
dditives, a density around 95% could be achieved.
The XRD patterns, shown in Fig. 2, reveal the presence of
nly anhydrite CS (PDF#37-1496) in the sintered specimens. The
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Fig. 6. Accumulated weight loss of CaSO4-based specimens within a time frame
of  28 days. The CS specimens collapsed completely within 28 days. The CS1SPCN
specimens were not degraded completely after soaking for 28 days. The degradation
time for CS1SPCN specimens can be estimated by extrapolating the approximate
s
(
p
2
C
m
o
s
f
s
n
t
p
e
c
pig. 4. Compressive strength of CaSO4-based specimens. The specimens were pre-
ared by sintering at 1100 ◦C for 1 h. Five specimens were used for each group.
mount of sintering additives used in the present study was  only
 wt%; no reaction phase was detected in the XRD patterns. Typical
icrographs for the CS-based specimens are shown in Fig. 3. The
ize of CS grains in the sintered pure CS specimen is around 20 m.
he addition of a very small amount of sintering additives reduces
he size of CS grains to around 5 m.
The compressive strength of CS-based specimens is shown in
ig. 4. The strength measurement was carried out within three days
fter the sintering. The compressive strength of pure CS is 66 MPa.
owever, the strength of pure CS tablet decreased slowly with the
ncrease of time, as the specimens were kept under ambient con-
itions. The pure CS tablet even collapsed into several pieces after
torage for 1–2 months. As the density was increased following the
ddition of sintering additives, the strength was  also enhanced.
or example, as the CS was doped with a small amount of SiO2,
2O5 and CaO (e.g. CS1SPC specimen), the compressive strength
ncreases signiﬁcantly to 155 MPa. This strength value is close to
hat of the cortical bones [5]. Furthermore, no noticeable decrease
n strength was noted for the doped CS specimens after the storage
f 1–2 years.The pH value of the Hank’s solution soaked with the CS-based
pecimens was also monitored. The values are shown as a function
f soaking time in Fig. 5. The pH value of blank Hank’s solution
ig. 5. pH value of the Hank’s solution after soaking with CaSO4-based specimens
or various times. Eight specimens were used for each datum point.
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Ttraight line to 100% weight loss. Eight specimens were used for each datum point.
without specimens) was recorded as a basis for comparison. The
H value of blank Hank’s solution is 7.4. Within a time frame of
8 days, the pH value of the Hank’s solution after soaking with the
S-based specimens varies within a range from 7.4 to 7.9, which
eets the requirements for materials used within a human body.
In order to evaluate the degradation behavior, weight loss
f the specimens in Hank’s solution was also monitored. Fig. 6
hows accumulated weight loss for the CS-based specimens as a
unction of soaking time. As the weight loss reaches 100%, the
pecimen degrades completely in the Hank’s solution. The time
eeded for complete degradation is considered the degradation
ime. Although the CS1SPCN specimen degradation was incom-
lete after 28 days, the degradation time can be estimated from the
xtrapolation to 100% weight loss indicated in Fig. 6. The time for
omplete degradation and its rate are summarized in Table 1. The
ure CS specimen degrades completely within 11 days. The degra-
ation rate is thus as high as 9% per day. The degradation time for
he sintered CS1SPCN specimen reaches 50 days. The correspond-
ng degradation rate is signiﬁcantly reduced.
A cell cytotoxicity test was  needed to evaluate the potential of
he new biomaterials. In the present study, the L929 mouse ﬁbro-
last cells were utilized for the test. The cell proliferation assay was
onducted to evaluate the cell viability. In order to verify the reli-
bility of the test, the MEM  and MEM  + 10% DMSO solutions were
sed as the negative and positive control groups, respectively. The
ell density in the negative control group was treated as the basis
or comparison. As 10 vol% DMSO solution was  added into the MEM
positive control group), the cell viability dropped to a low value
<10%). Fig. 7 shows cell viability after culturing with extracts from
he CS1SP, CS1SPN, CS1SPC, and CS1SPCN specimens after various
mounts of time. The ﬁgure indicates that there is no severe cyto-
oxicity against L929 cells after incubating for 24, 48 and 72 h in the
xtracts of CS-based specimens. This suggests that the addition of
dditives caused no adverse effect on the biocompatibility of CS.
Fig. 8 shows the cytotoxicity results from the MTT  assay. The
ell viability in the presence of negative control (MEM,  denoted as
trl.−), positive control (MEM + 10 vol% DMSO, denoted as ctrl.+),
nd extracts of specimens after culturing for 24 h is shown in the
gure. The cell viability of positive control is the lowest (3.6 ± 2.3%).
he cell viability of negative control and the extracts from CS-based
106 S.-T. Kuo et al. / Journal of Asian Ceram
Fig. 7. Results for the proliferation assay test. The negative control (MEM, denoted
as ctrl.−) and positive control (MEM + 10 vol% DMSO, denoted as ctrl.+) groups were
used for comparison purpose. Data were taken from six independent experiments.
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sig. 8. Cell viability after the MTT assay test. Data were taken from six independent
xperiments.
pecimens was high. It conﬁrms that the CS-based specimens show
ittle cytotoxicity against L929 cells after culturing for 24 h.
. Discussion
Densiﬁcation (increase of density) and coarsening (growth of
rains) are two processes that both take place simultaneously dur-
ng sintering. The densiﬁcation of ceramics is usually controlled
y the lattice diffusion and/or grain boundary diffusion of the ions
ith the slowest moving rate [15]. The SO42− units are expected
o diffuse more slowly compared to Ca2+ ions, owing to their rela-
ively large size. The diffusion of sulfur ions or oxygen ions during
intering may  be possible due to the decomposition of the SO42−
nits at elevated temperature. The growth of grains depends on
he interactions between the grain boundaries and pores [15]. The
icrographs (Fig. 3) show that the pores were located mainly at
he boundaries of the CS grains. This suggests that the growth of CS
rains is likely controlled by the movement of pores.The starting material used in the present study was  hemihy-
rate CS. This compound assembles into an anhydrite phase after
ring above 300 ◦C [16]. Although there is no other phase detected
fter the addition of sintering additives, a very minor peak shift
5
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as noted from the XRD patterns (Fig. 2). It implies that some
f the sintering additives may  dissolve into CS grains. However,
any ﬁne particles can also be found at the boundaries of the CS
rains (Fig. 3). These ﬁne particles are not observed in the pure
S specimen, suggesting that the ﬁne particles are formed due to
he addition of sintering additives. The presence of second-phase
articles prohibits the movement of the grain boundary; the grain
ize is thus smaller. The reﬁned microstructure may  consequently
nduce a better sinterability [17], allowing the density of doped CS
pecimens to therefore be higher. The strength of ceramics exhibits
 power-law relationship with the amount of porosity [18]. The
ncrease of relative density thus enhances the strength of CS speci-
ens. The ﬁner grain size may  also contribute in part to the increase
f compressive strength.
An additional signiﬁcant ﬁnding to note is that, as sintering
dditives were used, no signiﬁcant decrease in strength was found
fter the specimens were stored for 1–2 years. This implies that
he shelf time of sintered CaSO4-based tablets could be very long.
urthermore, a decrease in density was discovered when the sin-
ering temperature was above 1100 ◦C. This could be related to the
olume expansion accompanied with the phase transformation of
S [16].
Several factors, such as composition, the amount of micro- and
acropores, particle size and crystallinity, all affect the degra-
ation behavior to various extents [19]. By using the sintering
dditives, the degradation rate of CS-based material can be tai-
ored. Fig. 6 and Table 1 demonstrate that the degradation rate
f CS-based specimens decreases signiﬁcantly after the use of
he sintering additives. For example, the degradation time and
ate for CS1SPCN (CS + 0.56% SiO2 + 0.11% P2O5 + 0.21% CaO + 0.12%
aHCO3) were respectively 50 days and 2% per day. A slight shift
f XRD anhydrite CS peaks was observed as a small amount of SiO2
nd CaO was  added into the CS (Fig. 2), indicating that a small
mount of Si4+ and O2− ions may  dissolve into CS during sintering.
ome Ca SO4 bonds may  have been replaced with Si SO4 bonds;
ome S O bonds (in SO42−) with Si O bonds. The sintering abil-
ty of CS was thus modiﬁed, which in turn altered the degradation
ate.
The addition of SiO2 may  induce the formation of calcium sil-
cate. Calcium silicate is also biocompatible [7]. The decrease in
egradation rate can be partially attributed to the change in bond-
ng [20]. It may  also be attributed in part to the lower solubility of
alcium silicate [7].
The MTT  assay (Fig. 8) shows little cytotoxicity against L929 cells
rom the CS-based specimens. An important ﬁnding was that the
esults from the MTT  assay were consistent with those from the
ell proliferation assay (Fig. 7). It is also interesting to note that
he viability of L929 cells in the extracts of CS1SPC and CS1SPCN is
lightly higher than that of the negative control. According to previ-
us studies [21–24], the dissolution of biomaterials could affect cell
roliferation. The ionic species of the sintered CS-based specimens
re composed of calcium and silicate. These ions may  stimulate cell
roliferation [23,24].
The sintered CS-based specimens can release some ions into
he surrounding liquid. The cytotoxicity tests (Figs. 7 and 8)
emonstrate that the toxicity of CS-based specimens is very low.
urthermore, their pH values are acceptable. This suggests that
he potential for using the CS-based specimens as bone graft
ubstitutes is high.. Conclusions
After the sintering behavior of CS was  investigated in the present
tudy, the following conclusions can be drawn:
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. The CS can be sintered to a density above 90% by using a press-
ureless sintering technique. However, the degradation rate of
sintered CS is relatively fast in Hank’s solution.
. The addition of sintering additives, such as SiO2, P2O5, CaO, and
NaHCO3, enhances the densiﬁcation of CS. More importantly,
through the solution of these sintering additives into CS grains,
the degradation rate of CS is slowed down.
. Due to the densiﬁcation of CS being improved through the
addition of sintering additives, the compressive strength is con-
sequently improved.
. The shelf-time of the CaSO4-based specimens can be very long.
. The CS is transformed from hemihydrate to anhydrite after sin-
tering at elevated temperature. The cytotoxicity of anhydrous CS
is very low.
. By choosing suitable sintering additives, the degradation rate of
sintered CS is tunable.
The sintered CS specimens are potential candidates for bone
raft substitutes.
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